Завершено
Фаза II
Россия
CO-1.01; Gemcitabine · Clovis Oncology, Inc.
A Phase II Randomized, Open-Label, Multicenter Study Comparing CO-1.01 With Gemcitabine as First-Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma